5-amino-1mq safety human studies (5mg) 5-Amino-1MQ Vial - 10mg

2018. Therapeutic potential of NAD-boosting molecules in vivo

The thigh sits right there in front of you while seated, fully visible, fully accessible

Low to moderate intensity cardio (walking, cycling, light jogging at conversational pace) performed during the 30-60 minute fasting window maximizes fat oxidation from mobilized fatty acids

Phase 2 trial data (Jastreboff et al., NEJM 2023) demonstrated average weight reductions of approximately 1724% over 48 weeks notably higher than currently approved GLP-1 receptor agonists such as semaglutide, though direct comparisons are limited by differences in trial populations and designs

Lost 3 lbs so far, more energy

Route of Administration: Intramuscular (IM) or Subcutaneous (SC) injection